Acotec Scientific Holdings Ltd. has announced that it has received registration approval from the PRC National Medical Products Administration for its Peripheral Scoring Balloon Dilatation Catheter, E-Peridge®. This approval, granted on May 27, 2025, marks a significant milestone for the company as it enhances its product portfolio aimed at treating stenotic lesions in peripheral vessels, including the iliac and renal arteries. The E-Peridge® catheter is designed to provide effective anchoring and reduce elastic recoil of plaques, thus minimizing vascular injury. Acotec plans to initiate marketing activities in the PRC market, although the company cautions that successful commercialization is not guaranteed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.